Tumour‐derived substrate‐adherent cells promote neuroblastoma survival through secreted trophic factors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour‐derived substrate‐adherent cells promote neuroblastoma survival through secreted trophic factors
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-01
DOI
10.1002/1878-0261.12969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives
- (2020) Laurence Blavier et al. Cancers
- Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
- (2020) Caroline Hochheuser et al. STEM CELLS AND DEVELOPMENT
- Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
- (2019) John Inge Johnsen et al. Frontiers in Molecular Neuroscience
- Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells
- (2017) Rui Li et al. Oncotarget
- Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
- (2017) KeeSoo Nam et al. Oncotarget
- The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder
- (2016) Nancy Ratner et al. ANNALS OF NEUROLOGY
- Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models
- (2016) S. Y. Park et al. MOLECULAR CANCER THERAPEUTICS
- Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity
- (2016) J Wu et al. Cell Death & Disease
- PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models
- (2015) Helen Y. Zou et al. CANCER CELL
- Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid
- (2015) Evgeny Akkuratov et al. CNS & Neurological Disorders-Drug Targets
- Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
- (2015) Andrey V. Reshetnyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
- (2015) Phillip B. Murray et al. Science Signaling
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
- (2015) Jikui Guan et al. eLife
- Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
- (2015) Phillip B. Murray et al. Science Signaling
- Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3
- (2015) Xiaoli Yao et al. PLoS One
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Essential role of GATA3 in regulation of differentiation and cell proliferation in SK-N-SH neuroblastoma cells
- (2014) HONGWEI PENG et al. Molecular Medicine Reports
- The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer
- (2014) L. Friboulet et al. Cancer Discovery
- SPARC expression induces cell cycle arrest via STAT3 signaling pathway in medulloblastoma cells
- (2011) Chandramu Chetty et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SPARC Stimulates Neuronal Differentiation of Medulloblastoma Cells via the Notch1/STAT3 Pathway
- (2011) P. Bhoopathi et al. CANCER RESEARCH
- Emerging importance of ALK in neuroblastoma
- (2011) Anna M. Azarova et al. SEMINARS IN CANCER BIOLOGY
- Imaging of Metastatic CNS Neuroblastoma
- (2010) Nicholas D'Ambrosio et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
- (2009) Cinzia Lavarino et al. BMC CANCER
- Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
- (2009) Thomas R Webb et al. Expert Review of Anticancer Therapy
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now